Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · IEX Real-Time Price · USD
2.080
+0.030 (1.46%)
At close: Jul 2, 2024, 4:00 PM
2.120
+0.040 (1.92%)
After-hours: Jul 2, 2024, 6:46 PM EDT
Cardiff Oncology Market Cap
Cardiff Oncology has a market cap or net worth of $93.03 million as of July 2, 2024. Its market cap has increased by 41.59% in one year.
Market Cap
93.03M
Enterprise Value
27.84M
1-Year Change
41.59%
Ranking
Category
Stock Price
$2.08
Market Cap Chart
Since June 20, 2007, Cardiff Oncology's market cap has decreased from $1.11B to $93.03M, a decrease of -91.61%. That is a compound annual growth rate of -13.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 91.70M | 38.73% |
Dec 29, 2023 | 66.10M | 5.76% |
Dec 30, 2022 | 62.50M | -73.71% |
Dec 31, 2021 | 237.70M | -62.60% |
Dec 31, 2020 | 635.50M | 6,519.79% |
Dec 31, 2019 | 9.60M | -20.66% |
Dec 31, 2018 | 12.10M | 3.42% |
Dec 29, 2017 | 11.70M | -81.80% |
Dec 30, 2016 | 64.30M | -59.94% |
Dec 31, 2015 | 160.50M | 97.42% |
Dec 31, 2014 | 81.30M | -25.07% |
Dec 31, 2013 | 108.50M | 10.38% |
Dec 31, 2012 | 98.30M | 166.40% |
Dec 30, 2011 | 36.90M | 5.73% |
Dec 31, 2010 | 34.90M | -93.61% |
Dec 31, 2008 | 546.30M | -50.74% |
Dec 31, 2007 | 1.11B | - |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Clearside Biomedical | 92.67M |
Relmada Therapeutics | 92.63M |
InterCure | 92.51M |
111, Inc. | 92.05M |
Eupraxia Pharmaceuticals | 91.91M |
Cellectar Biosciences | 91.41M |
Asensus Surgical | 91.30M |
Tiziana Life Sciences | 91.29M |